Trump-Ordered US Review Concludes NHS Puberty Blocker Trial Is Unethical
A US government review ordered by President Trump has torched the NHS’s proposed trial of puberty blockers for children – branding it “not ethical” and warning of “significant harms.” The report published by the Department of Health and Human Services later today, echoes the findings of the Cass Review but goes further in its warnings. The researchers say that the high risk of infertility from puberty blockers in particular should prevent their current use in trials…
Cass recommended a trial of puberty blockers to establish both benefits and harms – a process the NHS is now designing. Though the US report concludes that the trial would “conflict with well-established ethical standards for human subjects research.” Oof…
Although the authors of the review remain anonymous – out of fear of threats from gender ideologues – one source close to the process is openly critical of Trump, saying: “We have a choice between bad and worse – bad is letting the Trump administration address this, worse is allowing this field of medicine to go completely unregulated and see kids sterilised and have breasts amputated with zero accountability.” The report concludes:
“We can be certain in the ordinary sense of ‘certain’ that these interventions cause harm, even if we do not have ‘high certainty’ evidence in the technical sense.”
The NHS facing heat from across the pond…
Read the report in full below: